Ocular Toxicity of Iron Chelator Drugs among Thalassemia Patients; a Review
Transfusion dependent thalassemia is a hematological condition characterized by imbalance in synthesis of alpha and beta subunits of hemoglobin. The consequence of regular and repeated transfusions is iron deposition in different organs. In order to survive, these patients need iron chelator drugs. The oldest drug of this group is desferrioxamine which is administered subcutaneously or intravenously. Nowadays, oral iron chelator drugs, including deferiprone, deferasirox are in more widespread use since they are more convenience to use. In this review the ocular toxicity of these chelator drugs is discussed.
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.